Pays: Malte
Langue: anglais
Source: Malta Medicines Authority
TRIFLUOPERAZINE HYDROCHLORIDE
Mercury Pharmaceuticals Limited Capital House, 85 King William Street, London EC4N 7BL, United Kingdom
N05AB06
TRIFLUOPERAZINE HYDROCHLORIDE 1 mg/5ml
SYRUP
TRIFLUOPERAZINE HYDROCHLORIDE 1 mg/5ml
POM
PSYCHOLEPTICS
Withdrawn
2006-03-27
P h a rm a C o d e READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The product is known by the name above but will be referred to as Stelazine Tablets throughout the rest of this leaflet. IN THIS LEAFLET: 1. What Stelazine Tablets are and what they are used for 2. Before you take Stelazine Tablets 3. How to take Stelazine Tablets 4. Possible side effects 5. How to store Stelazine Tablets 6. Further information 1. WHAT STELAZINE TABLETS ARE AND WHAT THEY ARE USED FOR Stelazine Tablets contain the active ingredient trifluoperazine hydrochloride, which belongs to a class of drugs called phenothiazine tranquilisers. It influences the activity of certain brain cells by decreasing the effect of dopamine, a natural chemical in the brain. • At a low dose, Stelazine Tablets are used to manage anxiety and depression. It is used in this way for short periods of time • Stelazine tablets may also be used to treat nausea (feeling sick) and vomiting (being sick) • At high doses, Stelazine Tablets are used to treat and prevent relapses of schizophrenia (a serious mental illness) and related conditions. 2. BEFORE YOU TAKE STELAZINE TABLETS DO NOT TAKE STELAZINE TABLETS IF: • You know that you are allergic to trifluoperazine hydrochloride or any of the Lire le document complet
Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Stelazine 1mg/5ml Syrup Trifluoperazine 1mg/5ml Syrup 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml dose contains 1 mg trifluoperazine present as the hydrochloride. 3 PHARMACEUTICAL FORM A clear, pale yellow, peach flavoured syrup. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Low dosage: ‘Stelazine’ is indicated as an adjunct in the short-term management of anxiety states, depressive symptoms secondary to anxiety and agitation. Orally it is also indicated in the symptomatic treatment of nausea and vomiting. High dosage: 'Stelazine' is intended for the treatment of symptoms and prevention of relapse in schizophrenia and in other psychoses, especially of the paranoid type, but not in depressive psychoses. It may also be used as an adjunct in short-term management of severe psychomotor agitation and of dangerously impulsive behaviour in, for example, mental subnormality. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE: ADULTS: _Low dosage_: 2-4 mg a day given in divided doses, according to the severity of the patient's condition. If necessary, dosage may be increased to 6 mg a day, but above this level extrapyramidal symptoms are more likely to occur in some patients. _High dosage_: The recommended starting dosage for physically fit adults is 5 mg twice a day after a week this may be increased to 15 mg a day. If necessary, further increases of 5 mg Page 2 of 8 may be made at three-day intervals, but not more often. When satisfactory control has been achieved, dosage should be reduced gradually until an effective maintenance level h Lire le document complet